View Item 

Show simple item record

Inpatient Treatment of Headache: An Evidence-Based Assessment
dc.contributor.authorFreitag, Frederick G.en_US
dc.contributor.authorLake, Alvin E.en_US
dc.contributor.authorLipton, Richard B.en_US
dc.contributor.authorCady, Rogeren_US
dc.contributor.authorDiamond, Seymouren_US
dc.contributor.authorSilberstein, Stephen D.en_US
dc.date.accessioned2010-06-01T19:24:29Z
dc.date.available2010-06-01T19:24:29Z
dc.date.issued2004-04en_US
dc.identifier.citationFreitag, Frederick G.; Lake, Al; Lipton, Richard; Cady, Roger; Diamond, Seymour; Silberstein, Stephen (2004). "Inpatient Treatment of Headache: An Evidence-Based Assessment." Headache: The Journal of Head and Face Pain 44(4): 342-360. <http://hdl.handle.net/2027.42/72549>en_US
dc.identifier.issn0017-8748en_US
dc.identifier.issn1526-4610en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72549
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15109359&dopt=citationen_US
dc.format.extent130576 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights2004 By the American Headache Societyen_US
dc.titleInpatient Treatment of Headache: An Evidence-Based Assessmenten_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Diamond Headache Clinic, Chicago and Finch University of Health Sciences, Chicago Medical School, North Chicago (Drs. Freitag and Diamond), Ill; Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove, Ill (Dr. Freitag); Michigan Headache and Neurological Institute, Ann Arbor, Mich (Dr. Lake); Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, NY (Dr. Lipton);  Headache Care Center, Springfield, Mo (Dr. Cady); and Thomas Jefferson University and Headache Center, Philadelphia, Pa (Dr. Silberstein).en_US
dc.identifier.pmid15109359en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72549/1/j.1526-4610.2004.04093.x.pdf
dc.identifier.doi10.1111/j.1526-4610.2004.04093.xen_US
dc.identifier.sourceHeadache: The Journal of Head and Face Painen_US
dc.identifier.citedreferenceSaper JR. Daily chronic headache. Neurol Clin. 1990; 8: 891 - 901.en_US
dc.identifier.citedreferenceSolomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache–comparison to criteria for chronic tension type headache. Cephalalgia. 1992; 12: 365 - 368.en_US
dc.identifier.citedreferencePfaffenrath V, Isler H. Evaluation of the nosology of chronic tension type headache. Cephalalgia. 1993; 13 ( suppl 12 ): 60 - 62.en_US
dc.identifier.citedreferenceMathew NT. Transformed migraine. Cephalalgia. 1993; 13 ( suppl 12 ): 78 - 83.en_US
dc.identifier.citedreferenceSilberstein SD, Lipton RB, Sliwinski M. Classification of daily and near daily headaches: field trial of revised IHS criteria. Neurology. 1996; 47: 871 - 875.en_US
dc.identifier.citedreferenceManzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia. 1995; 15: 37 - 43.en_US
dc.identifier.citedreferenceSanin LC, Mathew NT, Bellmeyer LR, Ali S. The International Headache Society (IHS) headache classification as applied to a headache clinic population. Cephalalgia. 1994; 14: 443 - 446.en_US
dc.identifier.citedreferenceLipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994; 34: 319 - 328.en_US
dc.identifier.citedreferenceRothrock J, Patel M, Lyden P, Jackson C. Demographic and clinical characteristics of patients with episodic migraine versus chronic daily headache. Cephalalgia. 1996; 16: 44 - 49.en_US
dc.identifier.citedreferenceMathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987; 27: 102 - 106.en_US
dc.identifier.citedreferenceMathew NT. Chronic daily headache: clinical features and natural history. In: Nappi G, ed. Headache and Depression: Serotonin Pathways as a Common Clue. New York: Raven Press; 1991.en_US
dc.identifier.citedreferenceKoenig MA, Gladstein J, McCarter RJ, Hershey AD, Wasiewski W. Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache. 2002; 42: 491 - 500.en_US
dc.identifier.citedreferenceSandrini G, Manzoni GC, Zanferrari C, Nappi G. An epidemiological approach to the nosology of chronic daily headache. Cephalalgia. 1993; 13 ( suppl 12 ): 72 - 77.en_US
dc.identifier.citedreferenceSilberstein SD. Tension type and chronic daily headache. Neurology. 1993; 43: 1644 - 1649.en_US
dc.identifier.citedreferenceMathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982; 22: 66 - 68.en_US
dc.identifier.citedreferenceBreslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998; 18 ( suppl 22 ): 56 - 61.en_US
dc.identifier.citedreferenceKessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med. 1997; 27: 861 - 873.en_US
dc.identifier.citedreferenceClouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Pharmacoeconomics. 1994; 28: 659 - 664.en_US
dc.identifier.citedreferenceScher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998; 38: 497 - 506.en_US
dc.identifier.citedreference20.  National Bureau of Economic Research. Trends in the Well Being of American Women, 1970-1995. Cambridge, MA: National Bureau of Economic Research; 1998. NBER Working Paper 6206.en_US
dc.identifier.citedreferenceRasmussen BK. Epidemiology of headache. Cephalalgia. 1995; 15: 45 - 68.en_US
dc.identifier.citedreferenceLavados PM, Tenham E. Epidemiology of tension type headache in Santiago, Chile: a prevalence study. Cephalalgia. 1998; 18: 552 - 558.en_US
dc.identifier.citedreferenceWong TW, Wong KS, Yu TS, Kay R. Prevalence of migraine and other headaches in Hong Kong. Neuroepidemiology. 1995; 14: 82 - 91.en_US
dc.identifier.citedreferenceTekle Haimanot R, Seraw B, Forsgren L, Ekbom K, Ekstedt J. Migraine, chronic tension type headache, and cluster headache in an Ethiopian rural community. Cephalalgia. 1995; 15: 482 - 488.en_US
dc.identifier.citedreferenceNewman LC, Lipton RB, Stewart WF. Severe daily headaches in a population sample: results from the American Migraine Study [abstract]. Headache. 1994; 34: 295.en_US
dc.identifier.citedreferenceHu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999; 159: 813 - 818.en_US
dc.identifier.citedreferenceOsterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the US. Pharmacoeconomics. 1992; 2: 67 - 76.en_US
dc.identifier.citedreferenceFishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia. 1999; 19: 50 - 57.en_US
dc.identifier.citedreferenceRome HP, Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med. 2000; 1: 7 - 23.en_US
dc.identifier.citedreferenceVon Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992; 50: 133 - 149.en_US
dc.identifier.citedreferenceVon Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population based diary study. Neurology. 1998; 50: 1741 - 1745.en_US
dc.identifier.citedreferenceFishman P, Von Korff M, Lozano P, et al. Chronic care costs in managed care. Health Affairs. 1997; 16: 239 - 247.en_US
dc.identifier.citedreferenceCady R, Schreiber C. Pharmacoeconomics implication of migraine and migraine therapies. In press.en_US
dc.identifier.citedreferenceVillareal SS. A comparative study of selected patient variable risk factors in hospitalization for chronic headache. Headache. 1995; 35: 349 - 354.en_US
dc.identifier.citedreferenceRapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 1996; 36: 14 - 19.en_US
dc.identifier.citedreferenceSaper JR, Silberstein S, Gordon CD, Hamel RL, Swidan S. Handbook of Headache Management. A Practical Guide To Diagnosis of Head, Neck and Facial Pain. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 1999.en_US
dc.identifier.citedreferenceFreitag F, Cady R, eds. The National Headache Foundation Standards of Care. 3rd ed. National Headache Foundation, 2001.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Maliszewski M. Inpatient treatment of headache: long-term results. Headache. 1986; 26: 189 - 197.en_US
dc.identifier.citedreferenceLake AE III, Saper JR, Madden SF, Kreeger C. Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study. Headache. 1993; 33: 55 - 62.en_US
dc.identifier.citedreferenceFreitag FG. Headache clinics and inpatient treatment. In: Diamond ML, Solomon G, eds. Diamond and Dalessio's Practicing Physicians Approach to Headache. Baltimore: Williams and Wilkens, 1993.en_US
dc.identifier.citedreference41.  American Academy of Neurology. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus [ summary statement ]. Report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology. 1995; 45: 585 - 587.en_US
dc.identifier.citedreference42.  Headache Classification Committee of the International Headache Society, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8 ( suppl 7 ): 1 - 96.en_US
dc.identifier.citedreferenceMathew NT, Kurman R, Perez F. Drug induced refractory headache–clinical features and management. Headache. 1990; 30: 634 - 638.en_US
dc.identifier.citedreferenceDalessio DJ. The clonidine protocol. Headache Q. 1991; 2: 133-134.en_US
dc.identifier.citedreferenceSilberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology and efficacy. Headache. 2001; 41: 953 - 967.en_US
dc.identifier.citedreferenceGuidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998; 18: 455 - 462.en_US
dc.identifier.citedreferenceSmith R. Impact of migraine on the family. Headache. 1998; 38: 423 - 426.en_US
dc.identifier.citedreferenceTfelt-Hansen P, Krabbe AA. Ergotamine abuse. Do patients benefit from withdrawal ? Cephalalgia. 1981; 1: 29 - 32.en_US
dc.identifier.citedreferenceAla-Hurula V, MyllylÄ V, Hokkanen E. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia. 1982; 2: 189 - 195.en_US
dc.identifier.citedreferenceRaskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986; 36: 995 - 997.en_US
dc.identifier.citedreferenceBaumgartner C, Wessely P, Bingol C, Maly J, Holzner F. Long-term prognosis of analgesic withdrawal inpatients with drug induced headache. Headache. 1989; 29: 510 - 514.en_US
dc.identifier.citedreferenceDiener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol. 1989; 236: 9 - 14.en_US
dc.identifier.citedreferenceSilberstein SD, Schulman EA, Hopkins MF. Repetitive intravenous DHE in the treatment of refractory headaches. Headache. 1990; 30: 334 - 339.en_US
dc.identifier.citedreferenceSilberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992; 32: 439 - 445.en_US
dc.identifier.citedreferenceSchnider P, Maly J, Grunberger J, Aull S, Zeiler K, Wessely P. Improvement of decreased critical flicker frequency (CFF) in headache patients with drug abuse after successful withdrawal. Headache. 1995; 35: 269 - 272.en_US
dc.identifier.citedreferenceSchnider P, Auall S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia. 1996; 16: 481 - 485.en_US
dc.identifier.citedreferenceFord RG, Ford KT. Continuous intravenous dihydroergotamine in the treatment of intractable headache. Headache. 1997; 37: 129 - 136.en_US
dc.identifier.citedreferencePringsheim T, Howse D. In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study. Can J Neurol Sci. 1998; 25: 146 - 150.en_US
dc.identifier.citedreferenceMonzÓn MJ, LÁinez JM. Chronic daily headache: long-term prognosis following inpatient treatment. Headache Q. 1998; 9: 326 - 330.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Prager J, Gandhi S. Treatment of intractable cluster. Headache. 1986; 26: 42 - 46.en_US
dc.identifier.citedreferenceMather PJ, Silberstein SD, Schulman EA, Hopkins MM. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache. 1991; 31: 525 - 532.en_US
dc.identifier.citedreferenceMcBeath JG, Nanda A. Use of dihydroergotamine in patients with post-concussion syndrome. Headache. 1994; 34: 148 - 151.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Maliszewski M, Prager J, Gandhi S. Treatment of headache in an inpatient headache unit: long-term results [ abstract ]. Cephalalgia. 1985; 5 ( suppl 3 ): 440 - 441.en_US
dc.identifier.citedreferenceSaper JR. Treatment of ergotamine dependency: techniques, outcome, and recidivism [ abstract ]. Headache. 1987; 27: 306.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Solomon GD. Impact of inpatient headache treatment on subsequent medical care [ abstract ]. Headache. 1988; 28: 317.en_US
dc.identifier.citedreferenceLake AE III, Saper JR. Prospective outcome evaluation of an accredited inpatient headache program [ abstract ]. Headache. 1988; 28: 315.en_US
dc.identifier.citedreferenceWall DJ, Haugh MJ. Biofeedback as an adjunct to repetitive intravenous dihydroergotamine in the treatment of refractory headache [ abstract ]. Headache. 1993; 33: 285.en_US
dc.identifier.citedreferenceWeeks RE, Baskin SM, Rapoport AM, Sheftell FD. A prospective analysis of repetitive intravenous DHE in the treatment of refractory headache [ abstract ]. Headache. 1993; 33: 286.en_US
dc.identifier.citedreferenceSaper JR, Lake AE III, Madden S, Kreeger C. Comprehensive inpatient treatment for intractable head pain: patient factors associated with outcome [ abstract ]. Headache. 1994; 34: 514.en_US
dc.identifier.citedreferenceLoughner BA, Dawson GA, Casaly JS. Inpatient treatment of chronic daily headache: outcome measures [ abstract ]. Headache. 1995; 35: 306.en_US
dc.identifier.citedreferenceWeeks RE, Baskin SM, Rapoport AM, Sheftell FD. In patient headache treatment: analysis of out come post-discharge. [ abstract ]. Neurology. 1995; 45 ( suppl 4 ): A379.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Diamond ML, Urban GJ. IV histamine therapy in intractable cluster headaches [ abstract ]. Cephalalgia. 1996; 16: 358 - 359.en_US
dc.identifier.citedreferenceDiamond S, Freitag FG, Bambhvani S. IV histamine desensitization therapy and recidivism: chronic cluster headache patients [ abstract ]. Cephalalgia. 1997; 17: 457.en_US
dc.identifier.citedreferenceYoung, WB, Hopkins MM, Janyszek B, Primavera JP III. Repetitive intravenous DHE in the treatment of refractory post-traumatic headache [ abstract ]. Headache. 1994; 34: 297.en_US
dc.identifier.citedreferenceRobbins L, Remmes A. Outpatient repetitive intravenous dihydroergotamine. Headache. 1992; 32: 455 - 458.en_US
dc.identifier.citedreferenceRobbins L. Intravenous DHE and cost saving [ abstract ]. Headache. 1995; 35: 50.en_US
dc.identifier.citedreferenceDrucker P, Tepper S. Repetitive outpatient oral sumatriptan for detoxification for patients with transformed migraine with medication overuse. Headache. 1997; 37: 307 - 308.en_US
dc.identifier.citedreferenceSuhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Hussted IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19: 44 - 49.en_US
dc.identifier.citedreferencePini LA, Bigarelli M, Vitale G, Sternieri E. Headache associated with chronic use of analgesics: a therapeutic approach. Headache. 1996; 36: 433 - 439.en_US
dc.identifier.citedreferenceCasaly JS, Loughner BA, Chen M. Comparative impact of inpatient therapy versus exclusively outpatient management of highly disabled headache sufferers [ abstract ]. Headache. 1999; 39: 347 - 348.en_US
dc.identifier.citedreferencede Williams AC, Richardson PH, Nicholas MK, et al. Inpatient versus outpatient pain management: results of a randomized controlled trial. Pain. 1996; 66: 13 - 22.en_US
dc.identifier.citedreferenceHoodin F, Brines BJ, Lake III AE, Wilson J, Saper JR. Behavioral self-management in an inpatient headache treatment unit: increasing adherence and relationship to changes in affective distress. Headache. 2000; 40: 377 - 383.en_US
dc.identifier.citedreferenceGrazzi L, Andrasik F, D'Amico D, et al. Behavioral approach in the treatment of chronic daily headache with drug overuse: a 3-year follow-up study [ abstract ]. Cephalalgia. 2000; 20: 300.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1526-4610.2004.04093.x.pdf
Size:
127.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.